期刊
CLINICAL INFECTIOUS DISEASES
卷 52, 期 12, 页码 1458-1465出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/cir207
关键词
-
资金
- Dutch Ministry of Health
- Gilead Sciences
- ViiV Healthcare
- Merck
- Tibotec Therapeutics
- Bristol Myers Squibb
- Boehringer Ingelheim
- Abbott
- Gilead
- Roche
- ViiV
Background. The aim of this study was to investigate the association between immunodeficiency, viremia, and non-AIDS-defining malignancies (NADM). Methods. Patients starting combination antiretroviral therapy (cART) as of 1 January 1996 were selected from the AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort. In Cox models, risk factors for NADM were investigated. These included age, sex, transmission route, smoking, alcohol abuse, prior AIDS diagnosis, duration of exposure to cART, and estimated duration of human immunodeficiency virus infection. CD4+ cell count and viral load (VL) were considered as time-updated variables and as measures of cumulative exposure to CD4+ cell counts of <200, <350, or <500 cells/mm(3) and detectable VL >50, >400, and >1000 copies/mL, respectively. Results. In a cohort of 11,459 patients, 236 NADMs were diagnosed; 102 were caused by infection, and 134 were attributable to other causes. Median CD41 cell count at NADM diagnosis was 340 cells/mm(3) (range, 210-540 cells/mm(3)). Median time to first NADM after starting cART was 5.0 years (range, 2.2-8.2 years). In multivariate models, cumulative exposure to CD41 cell counts,200 cells/mm(3) remained significant (hazard ratio [HR], 1.12; range, 1.03-1.22) for each additional year of exposure. In stratified analyses, cumulative exposure to CD41 cell counts,200 cells/mm(3) was associated with malignancies possibly caused by infection (HR, 1.16; range, 1.03-1.31]) but was not associated with other types of cancers. No significant effect of viremia was seen in either type of cancer. Conclusions. Cumulative exposure to CD41 cell counts <200 cells/mm(3) during cART was associated with an increased risk of infection-related non- AIDS-defining malignancies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据